See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Arix Bioscience is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. The firm collaborates with exceptional entrepreneurs and provides the capital, expertise and global networks needed to help accelerate their ideas into important new treatments for patients. Arix focuses on late pre-clinical to clinical-stage ventures and covers a diversified range of therapeutic areas, with a particular emphasis on oncology across different therapeutic modalities including CAR-T, DNA damage response/synthetic lethality, bi-specific antibodies, targeted viruses, and antibody-drug conjugates (ADCs).
Notable quotes
“We are delighted to have formed this strategic partnership with BioMotiv and it demonstrates our support for medical innovation at all stages of development. We are pleased to be joining eminent research and investment organisations such as Biogen, Takeda and Charles River Laboratories within BioMotiv. Our corporate strategy is structured in such a way that we are unconstrained by geography or stage of company development.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Ensoma | Series B | $85m | 2023-05-16 |
| Evommune | Series B | $50m | 2023-03-28 |
| Harpoon Therapeutics | Post-IPO | — | 2023-03-28 |
| Sorriso Pharmaceuticals | Series A | $54m | 2021-12-22 |
| VelosBio | Series A | $58m | 2018-10-01 |
| Artios Pharma | unknown | — | — |
| Aura Biosciences | unknown | — | — |
| Disc Medicine | unknown | — | — |
| Autolus Therapeutics | unknown | — | — |
| Verona Pharma | unknown | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| 5AM Ventures | 2 |
| Sofinnova Ventures | 2 |
| OrbiMed | 1 |
| EQT Life Sciences | 1 |
| New Enterprise Associates | 1 |
| Takeda Ventures | 1 |
Fit check
Is Arix Bioscience plc a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit